Janux Therapeutics is a biotechnology company focused on developing advanced therapeutic methods for cancer immunotherapy. The company specializes in utilizing its platform, which combines antibody technology with targeted therapeutic agents, to enhance the body's natural defense against cancer cells. Janux is developing various products, including bioconjugates, that aim to specifically target and destroy cancer cells while minimizing side effects on healthy tissues.